0 NASDAQ Companies - December 11, 2018Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 30, 2018NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) — At the end of the settlement date of November 30, 2018, short […]Read More
0 NASDAQ Companies - December 11, 2018WillScot Announces Closing of Warrant Exchange OfferBALTIMORE, Dec. 11, 2018 (GLOBE NEWSWIRE) — WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative […]Read More
0 NASDAQ Companies - December 11, 2018Quotient Limited Announces Closing of Underwritten Offering of Ordinary SharesJERSEY, Channel Islands, Dec. 11, 2018 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the […]Read More
0 NASDAQ Companies - December 11, 2018Dave & Buster’s Achieves Record Third Quarter RevenueDouble-Digit Unit Growth Planned for FY 2019 DALLAS, Dec. 11, 2018 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), […]Read More
0 NASDAQ Companies - December 11, 2018Viveve Announces Closing of Public Offering of Shares of Common StockENGLEWOOD, Colo., Dec. 11, 2018 (GLOBE NEWSWIRE) — Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on […]Read More
0 NASDAQ Companies - December 11, 2018Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 DeficiencySingle, Global Pivotal Trial to Support Registration; Primary Endpoint of Arginine Reduction Expected to Initiate in Q2 2019; Topline Data […]Read More
0 NASDAQ Companies - December 11, 2018First Solar Announces Full-Year 2019 Financial GuidanceNet sales of $3.25 to $3.45 billion EPS of $2.25 to $2.75, inclusive of plant-start up and ramp costs of […]Read More
0 NASDAQ Companies - December 11, 2018Momenta Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional SharesCAMBRIDGE, Mass., Dec. 11, 2018 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific […]Read More
0 TSX News - December 11, 2018Almaden Reports 42% After-Tax IRR With 203,000 ozs Gold Equivalent Production per Year Over First 6 Years From Feasibility Study for the Ixtaca Precious Metals Project, MexicoVANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) — Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: […]Read More
0 NASDAQ Companies - December 11, 2018Fluidigm Announces Commencement of Public Offering of Common StockSOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and […]Read More